Lunit Inc. is an AI tool that aims to save lives through technology by providing AI solutions for cancer screening and treatment. Their AI technology can detect early-stage cancers, enabling timely management and increasing the chances of survival. Additionally, Lunit"s AI biomarker accurately predicts treatment response, enhancing the efficacy of immunotherapy. The tool has been widely recognized for its world-leading technology, and it has been ranked first in the CAMELYON Grand Challenge 2017. Lunit"s AI has been implemented in over 2,000 sites worldwide, and they have collaborations with global research and business partners. The tool"s potential applications span from cancer care in hospitals to precision oncology product development. Through their AI-powered solutions, Lunit aims to revolutionize cancer diagnosis and treatment.